How The Evidence Company goes beyond the black box - delivering traceable, trustworthy AI that clinicians can rely on.
Large language models (LLMs) powering today's popular chatbots are so complex that no one can determine how they produce their outputs - they are, in essence, black boxes that cannot explain their own reasoning.
An interpretable AI model surfaces the logic, criteria, and weightings behind every conclusion - so a human can follow the reasoning step by step and evaluate whether it is sound.
Every output can be linked back to the specific evidence or rules that produced it, creating a clear audit trail for clinicians, regulators, and researchers.
XAI systems are designed to be challenged. Humans retain the right to interrogate, override, or reject any conclusion - keeping AI as a tool that supports judgment, not one that replaces it.
LLM 'chain of thought' is still model-generated reasoning - it can hallucinate its own justifications, making it unreliable as a basis for clinical decisions. Attaching a source link isn't XAI either, it's just citation - the reasoning process that produced the answer remains entirely opaque. True XAI means the logic itself is structured, auditable, and directly derived from verified evidence - not merely pointed at it.
Question: "Is a colonoscopy appropriate for this patient?"
Yes, colonoscopy is the recommended screening method for patients over 50 with a family history of colorectal cancer. [Source: NHS website link]
Question: "Is a colonoscopy appropriate for this patient?"
Colonoscopy is indicated per NICE guideline NG151 (Rule 3.2) based on age >50 and family history. However, patient record flags sedation intolerance - this creates a clinical conflict. CT colonography is surfaced as an alternative (NICE NG151, Rule 4.1). Clinician review recommended before proceeding.
Our platform is purpose-built to address the fundamental limitations of standard LLMs in healthcare. Rather than relying on generative models alone, we combine structured clinical knowledge, retrieval-grounded reasoning, and conflict-tolerant XAI - producing outputs that clinicians can interrogate, verify, and trust.
Fetch structured clinical knowledge from verifiable sources.
Apply evidence-based, conflict-tolerant inference.
Highlight contradictions and resolve where possible.
Generate clinician-facing rationale grounded in patient data.
Define conversation topics, questions, and reporting criteria to match your clinical workflow.
Every output generated by our platform is anchored to a verified source, grounded in everything that patients say, and presented with full reasoning transparency. This is not a feature add-on - it is the architectural foundation of how our system works.
Our approach is grounded in a growing body of peer-reviewed research on explainable AI, uncertainty quantification, and safe deployment of clinical decision support systems. The papers below represent foundational and emerging work in this field - and the evidentiary basis for our platform's design principles.
Proceedings of the AAAI Conference on Artificial Intelligence, 2025 - Introduces ArgLLMs, a framework that augments LLMs with argumentative reasoning to enable explainable and contestable decision-making, combining zero-shot LLM capabilities with interpretable, contestable outputs. Link to full paper.
Artificial Intelligence journal, Elsevier - Argues that XAI should leverage insights from philosophy, psychology, and cognitive and social sciences about how people define, generate, select, evaluate, and present explanations, highlighting cognitive biases and social expectations that shape explanations. Link to full paper.
Informatics in Medicine Unlocked, 2023 - Examines the application of explainable AI methods in clinical decision support systems, addressing transparency, traceability, and the requirements for responsible AI deployment in healthcare settings. Link to full paper.
arXiv, 2026 - Presents ArgEval, a framework for decision support with LLMs using argumentative reasoning to provide faithful, explainable predictions with global contestability. Applied to glioblastoma treatment recommendations, demonstrating competitive performance with enhanced contestability. Link to full paper.
See how trustworthy clinical AI works in practice - request a personalised demonstration with our team.
See how AI recommendations are explained, sourced, and confidence-scored in a real clinical workflow context.
Understand our architecture, integration pathways, governance features, and compliance posture.
Review our validation methodology, uncertainty calibration benchmarks, and hallucination elimination approach in technical depth.
© 2026 The Evidence Company Ltd.

Explainable & Quantified Uncertainty for Safeguarded AI in Healthcare